Introduction
In early 2025, an astute clinician noted a higher-than-expected frequency of Burkholderia cepacia complex infections in lung transplant recipients. Two of these isolates were subsequently characterized by Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT), our real-time bacterial genomic surveillance system, as genetically indistinguishable Burkholderia sola infections. Reference Sundermann, Kumar and Griffith1 B. sola is a newly described environmental species within the B. cepacia complex, with limited documentation of human infection. Reference Morales-Ruíz, Larios-Serrato and Estrada-de Los Santos2 Here, we describe the investigation of this healthcare-associated cluster.
Cluster cases
Patient 1 is a 70-year-old individual with chronic respiratory failure due to idiopathic pulmonary fibrosis, admitted for lung transplant evaluation. A single lung transplantation was performed 36 days after admission. Sterility cultures of the harvested lung immediately prior to transplant grew an isolate identified by the clinical microbiology laboratory as B. cepacia complex, using matrix-assisted laser desorption ionization-time of flight spectrometry, as well as Acinetobacter calcoaceticus and methicillin-susceptible Staphylococcus aureus. On post-transplant day 2, bronchoalveolar lavage (BAL) cultures from the transplanted lung were positive for B. cepacia complex. The patient received a 2-week course of antibiotic treatment. Bacteremia with B. cepacia complex was detected on post-transplant day 34; the patient was transferred to the intensive care unit (ICU) two days later and subsequently died on post-transplant day 51 from multiorgan failure in the setting of septic shock. Whole genome sequencing was performed on Burkholderia isolates from the donor lung sterility culture and bloodstream isolates.
Patient 2 is a 70-year-old individual with interstitial lung disease who underwent single lung transplantation 15 days following hospital admission. Sterility cultures of the harvested lung immediately prior to transplant grew methicillin-susceptible Staphylococcus aureus and oropharyngeal flora including yeast, and Ureaplasma urealyticum by polymerase chain reaction. Post-operatively, the patient was clinically diagnosed with pneumonia for which the patient received multiple antimicrobials from post-transplant day 6 through 25. BAL cultures on post-transplant days 1, 4, 7, and 23 demonstrated no growth. The patient was transferred on post-transplant day 28 to a long-term acute care facility located within the acute care hospital. The patient continued to have respiratory failure requiring ventilation and underwent a BAL on post-transplant day 43 that grew B. cepacia complex for which antibiotics were administered and the patient continues to receive care at the time of this report.
One additional patient with B. cepacia complex was identified as spatiotemporally related within the cluster. Patient 3 was transferred from an acute care hospital with heart failure and multiple organ dysfunction, admitted to the same ICU room as Patient 2 (38 days after Patient 2 was transferred from the room), and a BAL culture grew B. cepacia complex on hospital day 3.
Epidemiologic and genomic investigation
All three patients were cared for in the same ICU, Patients 1 and 2 concomitantly. The lung transplant surgeries for Patients 1 and 2 occurred in separate operating rooms with different surgical teams. The bronchoscopy procedures for all three patients entailed no common bronchoscopes or procedural staff. Aside from ICU care, no significant epidemiological commonalities were found between Patient 3 when compared to Patients 1 and 2. An investigation into the organ procurement process revealed no evidence that the lungs for Patient 1 were contaminated during procurement and transport. On retrospective microbiological surveillance, no other patients with laboratory-confirmed Burkholderia cepacia complex identified as potentially related to this cluster within several months prior to the index case; at the time of this report, no subsequent cases have been identified. In response to the cluster, supervised terminal cleaning was conducted in both the shared ICU room and operating rooms where Patients 1 and 2 underwent transplantation to ensure thorough environmental decontamination.
Genomic comparison of isolates found 0 SNP differences between isolates from Patients 1 and 2, identified as B. sola species (sequence data available at BioProject PRJNA475751). These were genetically unrelated to the isolate from Patient 3, B. cenocepacia, and all other sequenced Burkholderia isolates at our institution (>36,000 SNPs).
The B. sola isolates were compared to publicly available Sequence Read Archive Burkholderia species genomes, including 76 strains of B. sola, and also found to be genetically distinct (>28,000 SNPs to the closest genome). Figure 1 displays a phylogenetic tree comparing patient isolates to the 76 B. sola genomes. Of the 76 B. sola genomes analyzed, 8 (10.5%) were derived from human sources, suggesting that clinical detection of this species is rare. Most isolates originated from environmental sources across diverse countries, including the United States, Brazil, Mexico, and Italy. Reference Velez, Aburjaile and Farias3
Figure 1. Phylogenetic analysis of UPMC patient Burkholderia sola isolates compared to publicly available B. sola genomes. UPMC Patient 1 is BC00103, BC00107, and BC00108 and UPMC Patient 2 is BC00106.
Discussion
This cluster represents the first reported healthcare-associated transmission of B. sola, resulting in clinically significant infection in two lung transplant recipients. Genomic and epidemiologic data support a donor-derived infection in the index patient with subsequent unit-based transmission to a second patient. In the context of B. cepacia complex outbreaks, systematic reviews have found that sources of transmission remain unidentified in approximately 25% of cases, and that common reservoirs include respiratory equipment and environmental surfaces—often affecting immunocompromised patients. Reference Shaban, Sotomayor-Castillo and Nahidi4,Reference Häfliger, Atkinson and Marschall5
Routine clinical microbiology initially identified these isolates as B. cepacia complex, with speciation as B. sola made possible through whole-genome sequencing. Traditional infection prevention efforts often rely on clinical recognition or laboratory detection of unusual organisms. Reference Baker, Huang and Letourneau6 Whole genome sequencing surveillance may enable early identification of transmission events and improve detection and cessation of rare or emerging pathogens, as demonstrated in this case and in prior work using genomic surveillance. Reference Sundermann, Kumar and Griffith1,Reference Sundermann, Chen and Kumar7,Reference Sundermann, Rosa and Harris8
Supplementary material
To view supplementary material for this article, please visit https://doi.org/10.1017/ice.2025.10261.
Acknowledgments
We thank our clinical laboratory team.
Funding statement
This work was funded in part by the National Institutes of Health (NIH) (R01AI127472). NIH played no role in data collection, analysis, or interpretation; study design; writing of the manuscript; or decision to submit for publication.
Competing interests
AJS is a consultant to Next Gen Diagnostics. LHH is on the scientific advisory board of Next Gen Diagnostics.
Open access
